The Washington Post @washingtonpost
Pfizer announced Tuesday that its maternal RSV vaccine, given during pregnancy, protected infants from developing severe symptoms during the first six months after birth — a critical window of vulnerability. https://t.co/cwrQcnyHvs — PolitiTweet.org